analyst
IB
NASDAQ · IBRX
ImmunityBio, Inc.
Healthcare · Biotechnology
$8.29
Down-$0.45 (-5.15%)
Updated Nov 1, 2026, 5:54 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.16B
- P/E ratio
- -5.96
- Dividend yield
- 0.00%
- 52-week range
- $1.95 – $12.43
- Volume
- 8.96M
- Avg. volume
- 10.1M
Price performance · IBRX
IBRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
IBRX closed at $8.29 after 20 trading sessions, down 20.13% for the selected period.
- Last close
- $8.29
- Period change
- -20.13%
- Period low
- $7.81
- Period high
- $10.51
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $8.48 | $8.725 | $8.1223 | $8.29 | 8.96M |
| Oct 29, 2026 | $8.75 | $8.935 | $8.5601 | $8.74 | 7.15M |
| Oct 28, 2026 | $8.61 | $8.83 | $8.48 | $8.81 | 7.17M |
| Oct 27, 2026 | $7.82 | $8.685 | $7.765 | $8.63 | 10.51M |
| Oct 26, 2026 | $8.23 | $8.28 | $7.75 | $7.81 | 11.05M |
| Oct 23, 2026 | $8.21 | $8.355 | $8.05 | $8.22 | 5.94M |
| Oct 22, 2026 | $8.53 | $8.84 | $8.02 | $8.31 | 12.74M |
| Oct 21, 2026 | $8.79 | $8.99 | $8.32 | $8.64 | 11.51M |
| Oct 20, 2026 | $8.31 | $8.90 | $8.11 | $8.77 | 14.11M |
| Oct 19, 2026 | $9.19 | $9.6972 | $8.305 | $8.42 | 19.57M |
| Oct 16, 2026 | $10.02 | $10.02 | $9.02 | $9.18 | 21.51M |
| Oct 15, 2026 | $10.20 | $10.50 | $9.815 | $10.00 | 20.01M |
| Oct 14, 2026 | $9.69 | $10.455 | $9.35 | $9.91 | 30.23M |
| Oct 13, 2026 | $10.00 | $10.0599 | $9.56 | $9.80 | 11.62M |
| Oct 12, 2026 | $10.59 | $10.62 | $10.05 | $10.12 | 11.06M |
| Oct 9, 2026 | $9.95 | $10.80 | $9.87 | $10.51 | 18.66M |
| Oct 8, 2026 | $9.63 | $10.045 | $9.43 | $9.91 | 10.49M |
| Oct 7, 2026 | $9.50 | $9.93 | $9.33 | $9.75 | 11.78M |
| Oct 6, 2026 | $10.325 | $10.36 | $9.61 | $9.69 | 16.89M |
| Oct 5, 2026 | $10.76 | $10.81 | $10.125 | $10.38 | 16.87M |
Latest IBRX news
The latest Smart Investors Daily articles mentioning IBRX.
Stock researchResearch & News · SID Coverage
Company
Market Activity
Research & News
Loading stock research…

